4
Changes in Ownership
Vor Biopharma Inc. Filed Acc 0001104659-21-016820
Director bought 2,979,566 shares at $18.00 ($53,632,188)
- Director acquired 7,143,025 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2021-02-09 | Conversion | +1,664,549 | 1,664,549 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2021-02-09 | Conversion | +280,330 | 280,330 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2021-02-09 | Conversion | +3,784,120 | 5,448,669 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2021-02-09 | Conversion | +1,414,026 | 1,694,356 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2021-02-09 | Purchase | +2,848,596 | $18.00 | $51,274,728 | 8,297,265 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2021-02-09 | Purchase | +130,970 | $18.00 | $2,357,460 | 1,825,326 | I |
| Derivatives | |||||||
| RA CAPITAL MANAGEMENT, L.P. Director | 2021-02-09 | Conversion · Series A-2 Preferred Stock | −22,637,875 | 0 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2021-02-09 | Conversion · Series A-2 Preferred Stock | −3,812,500 | 0 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2021-02-09 | Conversion · Series B Preferred Stock | −51,464,036 | 0 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2021-02-09 | Conversion · Series B Preferred Stock | −19,230,770 | 0 | I | ||
| Open-market purchases · 2,979,566 sh · avg $18.00 · $53,632,188 | |||||||
Loading xslF345X03/tm216001-1_4.xml…